Literature DB >> 10626860

A prospective, randomized, double-blind, placebo-controlled trial of glyceryl-trinitrate ointment in the treatment of children with anal fissure.

B Tander1, A Güven, S Demirbağ, Y Ozkan, H Oztürk, S Cetinkurşun.   

Abstract

BACKGROUND: Anal fissure in children usually is treated by sitz baths, stool softeners, and analgesic ointments. However, some cases are intractable to the treatment. In recent years, it has been reported that nitric oxide donors such as local glyceryl-trinitrate (GTN) ointment causes a reversible chemical sphincterotomy. Although the GTN ointment can be an alternative therapy for adult cases, it has not yet been studied in the children who suffer from anal fissure.
METHODS: Sixty-five children with anal fissure were divided randomly into 3 groups. Each group received double-blinded a topical ointment that contained either 0.2% GTN, 10% lidocaine, or placebo. These ointments were applied to the lowest part of the anal canal twice daily. Patients were periodically reviewed, and the study was ended after 8 weeks.
RESULTS: Complete healing of the fissure occurred in 26 of 31 (83.9%) patients treated with GTN, 7 of 14 (50%) patients treated with lidocaine, and 6 of 17 (35.2%) treated with placebo. In 29 of 31 (93.5%) GTN-treated patients, a total relief of symptoms was observed, whereas this occurred in 7 of 14 (50%) treated with lidocaine and 6 of 11 (35.3%) in the placebo group. The differences between the study group and control groups were highly statistically significant (P < .001).
CONCLUSION: The majority of children suffering from anal fissure will be cured and have relief of symptoms after topical application of GTN ointment to the anal canal.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626860     DOI: 10.1016/s0022-3468(99)90318-4

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

Review 1.  Symptomatic care and nitroglycerin in the management of anal fissure.

Authors:  Robin S McLeod; Justin Evans
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

2.  Practice tips. Novel uses for nitroglycerin.

Authors:  L Reynolds
Journal:  Can Fam Physician       Date:  2000-08       Impact factor: 3.275

Review 3.  Current concepts in anal fissures.

Authors:  Abraham A Ayantunde; Samuel A Debrah
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

4.  Double blind randomised controlled trial of topical glyceryl trinitrate in anal fissure.

Authors:  S E Kenny; T Irvine; C P Driver; A T Nunn; P D Losty; M O Jones; R R Turnock; G L Lamont; D A Lloyd
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

5.  Efficacy of lanolin and bovine type I collagen in the treatment of childhood anal fissures: a prospective, randomized, controlled clinical trial.

Authors:  Behçet Ilker Büyükyavuz; Cagri Savaş; Levent Duman
Journal:  Surg Today       Date:  2010-07-30       Impact factor: 2.549

6.  A prospective, randomized, double-blind study comparing the efficacy of diltiazem, glyceryl trinitrate, and lidocaine for the treatment of anal fissure in children.

Authors:  Muazez Cevik; Mehmet Emin Boleken; Ibrahim Koruk; Servet Ocal; Mehmet Emin Balcioglu; Asim Aydinoglu; Cetin Ali Karadag
Journal:  Pediatr Surg Int       Date:  2012-01-03       Impact factor: 1.827

Review 7.  Non surgical therapy for anal fissure.

Authors:  Richard L Nelson; Kathryn Thomas; Jenna Morgan; Abigail Jones
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 8.  A systematic review and meta-analysis of the treatment of anal fissure.

Authors:  R L Nelson; D Manuel; C Gumienny; B Spencer; K Patel; K Schmitt; D Castillo; A Bravo; A Yeboah-Sampong
Journal:  Tech Coloproctol       Date:  2017-08-09       Impact factor: 3.781

9.  Effects of warm water sitz bath on symptoms in post-anal sphincterotomy in chronic anal fissure--a randomized and controlled study.

Authors:  Pravin J Gupta
Journal:  World J Surg       Date:  2007-07       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.